{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:49:36Z","timestamp":1780645776017,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejrad.2022.110421","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T11:51:46Z","timestamp":1655985106000},"page":"110421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report"],"prefix":"10.1016","volume":"154","author":[{"given":"Romain","family":"Bec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Reynaud-Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Naud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Dufeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Di Bisceglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Coiffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Habert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/17460913.1.1.53","article-title":"Cystic fibrosis: a polymicrobial infectious disease","volume":"1","author":"Sibley","year":"2006","journal-title":"Future Microbiol."},{"issue":"2","key":"10.1016\/j.ejrad.2022.110421_b0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion Channel Modulators in Cystic Fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ejrad.2022.110421_b0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"10059","key":"10.1016\/j.ejrad.2022.110421_b0020","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"The Lancet."},{"issue":"17","key":"10.1016\/j.ejrad.2022.110421_b0025","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FPC.0000000000000246","article-title":"PharmGKB summary: ivacaftor pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"issue":"10212","key":"10.1016\/j.ejrad.2022.110421_b0035","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"The Lancet."},{"issue":"19","key":"10.1016\/j.ejrad.2022.110421_b0040","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcf.2014.06.011","article-title":"Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation","volume":"14","author":"Sheikh","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1183\/13993003.01918-2015","article-title":"Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor","volume":"48","author":"Chassagnon","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.ejrad.2022.110421_b0055","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3390\/jcm10091999","article-title":"Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor","volume":"10","author":"Arnaud","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.ejrad.2022.110421_b0060","doi-asserted-by":"crossref","first-page":"2101344","DOI":"10.1183\/13993003.01344-2021","article-title":"Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis","author":"Campredon","year":"2021","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid Improvement after Starting Elexacaftor\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110421_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpeds.2004.02.038","article-title":"High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests","volume":"145","author":"Brody","year":"2004","journal-title":"J. Pediatr."},{"issue":"5_suppl","key":"10.1016\/j.ejrad.2022.110421_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/00034894041130S506","article-title":"Imaging for Staging of Rhinosinusitis","volume":"113","author":"Zinreich","year":"2004","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"10","key":"10.1016\/j.ejrad.2022.110421_b0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.diii.2020.09.001","article-title":"Interobserver agreement issues in radiology","volume":"101","author":"Benchoufi","year":"2020","journal-title":"Diagn Interv Imaging."},{"issue":"2","key":"10.1016\/j.ejrad.2022.110421_b0085","doi-asserted-by":"crossref","first-page":"2100185","DOI":"10.1183\/13993003.00185-2021","article-title":"Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration","volume":"59","author":"Morrison","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.ejrad.2022.110421_b0090","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","article-title":"A Phase 3 Open-Label Study of Elexacaftor\/Tezacaftor\/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele","volume":"203","author":"Zemanick","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejrad.2022.110421_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.03.011","article-title":"Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","author":"Wucherpfennig","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejrad.2022.110421_b0100","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"issue":"2","key":"10.1016\/j.ejrad.2022.110421_b0105","doi-asserted-by":"crossref","first-page":"2003079","DOI":"10.1183\/13993003.03079-2020","article-title":"Efficacy of elexacaftor\/tezacaftor\/ivacaftor in patients with cystic fibrosis and advanced lung disease","volume":"57","author":"O\u2019Shea","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ejrad.2022.110421_b0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","article-title":"Cystic fibrosis: scoring system with thin-section CT","volume":"179","author":"Bhalla","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2022.110421_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","author":"Stapleton","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejrad.2022.110421_b0120","doi-asserted-by":"crossref","unstructured":"C. Le, H.C. McCrary, E. Chang, Cystic Fibrosis Sinusitis. In: Woodworth BA, Poetker DM, Reh DD, \u00e9diteurs. Advances in Oto-Rhino-Laryngology [Internet]. S. Karger AG; 2016 [quoted 16 Dec 2021]. p. 29\u201137. Available on: https:\/\/www.karger.com\/Article\/FullText\/444959.","DOI":"10.1159\/000444959"},{"issue":"3","key":"10.1016\/j.ejrad.2022.110421_b0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"12","key":"10.1016\/j.ejrad.2022.110421_b0130","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.healun.2021.08.009","article-title":"CFTR modulator use in post lung transplant recipients","volume":"40","author":"Benninger","year":"2021","journal-title":"J. Heart Lung Transplant."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X22002716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X22002716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:31:50Z","timestamp":1759995110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X22002716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"alternative-id":["S0720048X22002716"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2022.110421","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2022.110421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110421"}}